Research Article

Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study

Table 1

Basic clinical and neuropathological characteristics of study cases.

CaseGenderAge at Death (years)Illness Duration (years)PM delay (hours)COD

C01M66N/A23.00Global heart failure, hypopharynx carcinoma
C02M54N/A27.00Pneumonia, respiratory failure
C03M64N/A50.00Kearns-Sayre-Syndrome, resp. failure
C04M55N/A24.00Aspiration pneumonia
C05F60N/A9.00Circulatory collapse, cutaneous T-cell-lymphoma perianal carcinoma
C06M58N/A9.00Unknown
C07F104N/A9.50Chest infection

Mean value

PD01F86155.50Sudden collapse
PD02M782420.25Unknown
PD03F851813.50Bronchopneumonia, Breast Cancer with metastasis and PD
PD04F761013.50Unknown
PD05M77105.50Unknown
PD06M801916.00Unknown
PD07M8057.00Unknown
PD08F801310.00Old age and PD
PD09M8682.50Ischaemic bowel and atrial fibrillation
PD10F87922.00Gastrointestinal bleeding
PD11F811421.50Unknown
PD12M821110.00Pneumonia, Fractured neck of femur, Pulmonary embolisms, COPD, Dementia

Mean value

C: Control; PD: Parkinson’s disease; PM: Postmortem; COD: cause of death.